198 related articles for article (PubMed ID: 32687618)
1. ELABELA improves endothelial cell function via the ELA-APJ axis by activating the PI3K/Akt signalling pathway in HUVECs and EA.hy926 cells.
Wang X; Liang G; Guo Q; Cai W; Zhang X; Ni J; Tao Y; Niu X; Chen S
Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1953-1964. PubMed ID: 32687618
[TBL] [Abstract][Full Text] [Related]
2. Exposure to higher concentrations of exogenous ELABELA causes HTR-8/SVneo trophoblast cell dysfunction: A possible pathogenesis of pre-eclampsia.
Liu D; Luo D; Ge H; Zhang C; Wei S; Liang D; Tang D; Li J; Lin Y
Pregnancy Hypertens; 2022 Dec; 30():181-188. PubMed ID: 36308998
[TBL] [Abstract][Full Text] [Related]
3. ELABELA ameliorates hypoxic/ischemic-induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K/AKT and ERK1/2 pathways.
Fu J; Chen X; Liu X; Xu D; Yang H; Zeng C; Long H; Zhou C; Wu H; Zheng G; Wu H; Wang W; Wang T
Stem Cell Res Ther; 2020 Dec; 11(1):541. PubMed ID: 33317626
[TBL] [Abstract][Full Text] [Related]
4. Reduced ELABELA expression attenuates trophoblast invasion through the PI3K/AKT/mTOR pathway in early onset preeclampsia.
Wang L; Zhang Y; Qu H; Xu F; Hu H; Zhang Q; Ye Y
Placenta; 2019 Nov; 87():38-45. PubMed ID: 31546152
[TBL] [Abstract][Full Text] [Related]
5. ELABELA-APJ Axis Enhances Mesenchymal Stem Cell Proliferation and Migration via the METTL3/PI3K/AKT Pathway.
Xu D; Fu J; Liu X; Hong Y; Chen X; Li S; Hou J; Zhang K; Zhou C; Zeng C; Zheng G; Wu H; Wang T
Acta Naturae; 2024; 16(1):111-118. PubMed ID: 38698964
[TBL] [Abstract][Full Text] [Related]
6. The Elabela-APJ axis: a promising therapeutic target for heart failure.
Ma Z; Song JJ; Martin S; Yang XC; Zhong JC
Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083
[TBL] [Abstract][Full Text] [Related]
7. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
[TBL] [Abstract][Full Text] [Related]
8. ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ.
Zhou L; Sun H; Cheng R; Fan X; Lai S; Deng C
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E773-E781. PubMed ID: 30860880
[TBL] [Abstract][Full Text] [Related]
9. ELABELA-APJ-Akt/YAP Signaling Axis: A Novel Mechanism of Aerobic Exercise in Cardioprotection of Myocardial Infarction Rats.
Xi Y; Li Y; Ren W; Bo W; Ma Y; Pan S; Gong DW; Tian Z
Med Sci Sports Exerc; 2023 Jul; 55(7):1172-1183. PubMed ID: 36878020
[TBL] [Abstract][Full Text] [Related]
10. Apelin/APJ system protects placental trophoblasts from hypoxia-induced oxidative stress through activating PI3K/Akt signaling pathway in preeclampsia.
Ye L; Huang Y; Liu X; Zhang X; Cao Y; Kong X; Yuan X; Xu J; Zhu H
Free Radic Biol Med; 2023 Nov; 208():759-770. PubMed ID: 37774802
[TBL] [Abstract][Full Text] [Related]
11. Exacerbated pressor and sympathoexcitatory effects of central Elabela in spontaneously hypertensive rats.
Geng Z; Ye C; Tong Y; Zhang F; Zhou YB; Xiong XQ
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H124-H134. PubMed ID: 31834836
[TBL] [Abstract][Full Text] [Related]
12. SRC-3 Plays a Critical Role in Human Umbilical Vein Endothelial Cells by Regulating the PI3K/Akt/mTOR Pathway in Preeclampsia.
Yuan Y; Shan N; Tan B; Deng Q; Liu Y; Wang H; Luo X; He C; Luo X; Zhang H; Baker PN; Olson DM; Qi H
Reprod Sci; 2018 May; 25(5):748-758. PubMed ID: 28826365
[TBL] [Abstract][Full Text] [Related]
13. Elabela-APJ axis mediates angiogenesis via YAP/TAZ pathway in cerebral ischemia/reperfusion injury.
Li W; Xu P; Kong L; Feng S; Shen N; Huang H; Wang W; Xu X; Wang X; Wang G; Zhang Y; Sun W; Hu W; Liu X
Transl Res; 2023 Jul; 257():78-92. PubMed ID: 36813109
[TBL] [Abstract][Full Text] [Related]
14. The COL-4A1 polypeptide destroy endothelial cells through the TGF-β/PI3K/AKT pathway.
Li T; Ling Z; Xie K; Wang Y; Miao Z; Ji X; Li J; Hou W; Tang Q; Yuan X; Li N; Li C; Ding H
Sci Rep; 2021 Aug; 11(1):15761. PubMed ID: 34344927
[TBL] [Abstract][Full Text] [Related]
15. Elabela-APJ axis attenuates cerebral ischemia/reperfusion injury by inhibiting neuronal ferroptosis.
Xu P; Kong L; Tao C; Zhu Y; Cheng J; Li W; Shen N; Li R; Zhang C; Wang L; Zhang Y; Wang G; Liu X; Sun W; Hu W
Free Radic Biol Med; 2023 Feb; 196():171-186. PubMed ID: 36681202
[TBL] [Abstract][Full Text] [Related]
16. Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system.
Liu W; Yan J; Pan W; Tang M
Ann Transl Med; 2020 Mar; 8(5):243. PubMed ID: 32309390
[TBL] [Abstract][Full Text] [Related]
17. A novel peptide relieves endothelial cell dysfunction in preeclampsia by regulating the PI3K/mTOR/HIF1α pathway.
Xue L; Xie K; Wu L; Yu X; Long W; Li C; Jia R; Ding H
Int J Mol Med; 2021 Jan; 47(1):276-288. PubMed ID: 33236147
[TBL] [Abstract][Full Text] [Related]
18. Elabela-apelin receptor signaling pathway is functional in mammalian systems.
Wang Z; Yu D; Wang M; Wang Q; Kouznetsova J; Yang R; Qian K; Wu W; Shuldiner A; Sztalryd C; Zou M; Zheng W; Gong DW
Sci Rep; 2015 Feb; 5():8170. PubMed ID: 25639753
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of apelin and Elabela in cardiovascular disease.
Gao S; Chen H
Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
[TBL] [Abstract][Full Text] [Related]
20. ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway.
Chen Z; Wang Z; Hu Y; Lin H; Yin L; Kong J; Zhang Y; Hu B; Li T; Zheng X; Yang Q; Ye S; Wang S; Zhou Q; Zheng C
Inflammation; 2023 Dec; 46(6):2343-2358. PubMed ID: 37540330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
